NasdaqGS - Delayed Quote USD
Akero Therapeutics, Inc. (AKRO)
54.71
+0.43
+(0.79%)
At close: June 9 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,085,845 | 41 |
| Sales | 450,990 | 37 |
| Net Shares Purchased (Sold) | 634,855 | 78 |
| Total Insider Shares Held | 1.11M | -- |
| % Net Shares Purchased (Sold) | 134.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROLPH TIMOTHY PETER Officer | Sale at price 53.37 - 55.04 per share. | Direct | 2,044,634 | Jun 6, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.09 - 21.10 per share. | Direct | 791,004 | Jun 6, 2025 |
| IWICKI MARK T. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| HENDERSON JANE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| HARRISON SETH LORING Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| HEYMAN TOMAS J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| GRAHAM G. WALMSLEY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| XU YUAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| JUDY CHOU Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2025 |
| LAMY PATRICK Officer | Sale at price 49.40 - 51.04 per share. | Direct | 201,258 | Jun 2, 2025 |
| LAMY PATRICK Officer | Conversion of Exercise of derivative security at price 19.87 per share. | Direct | 79,480 | Jun 2, 2025 |
| LAMY PATRICK Officer | Sale at price 50.00 per share. | Direct | 200,000 | May 22, 2025 |
| LAMY PATRICK Officer | Conversion of Exercise of derivative security at price 44.37 per share. | Direct | 177,480 | May 22, 2025 |
| YALE CATRIONA Officer | Sale at price 38.20 - 39.91 per share. | Direct | 392,978 | May 15, 2025 |
| YALE CATRIONA Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 211,000 | May 15, 2025 |
| CHENG ANDREW Chief Executive Officer | Sale at price 41.00 - 41.63 per share. | Direct | 1,244,455 | May 12, 2025 |
| LAMY PATRICK Officer | Sale at price 42.31 - 42.76 per share. | Direct | 339,950 | May 7, 2025 |
| LAMY PATRICK Officer | Conversion of Exercise of derivative security at price 19.87 per share. | Direct | 158,960 | May 7, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 42.26 - 44.50 per share. | Direct | 542,864 | May 6, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 263,750 | May 6, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 41.03 per share. | Direct | 256,438 | Apr 24, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 131,875 | Apr 24, 2025 |
| YALE CATRIONA Officer | Sale at price 37.80 - 38.62 per share. | Direct | 343,962 | Apr 15, 2025 |
| YALE CATRIONA Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 191,440 | Apr 15, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 35.36 - 37.91 per share. | Direct | 224,262 | Apr 7, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 131,875 | Apr 7, 2025 |
| GRAHAM G. WALMSLEY Director | Purchase at price 43.01 - 44.75 per share. | Indirect | 8,787,921 | Mar 27, 2025 |
| YALE CATRIONA Officer | Sale at price 44.70 - 45.05 per share. | Direct | 447,605 | Mar 17, 2025 |
| YALE CATRIONA Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 211,000 | Mar 17, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 44.88 per share. | Direct | 23,158 | Mar 12, 2025 |
| YOUNG JONATHAN Chief Operating Officer | Sale at price 44.88 per share. | Direct | 27,242 | Mar 12, 2025 |
| CHENG ANDREW Chief Executive Officer | Sale at price 44.88 per share. | Direct | 78,001 | Mar 12, 2025 |
| WHITE WILLIAM RICHARD Chief Financial Officer | Sale at price 44.88 per share. | Direct | 30,339 | Mar 12, 2025 |
| YALE CATRIONA Officer | Sale at price 44.88 per share. | Direct | 27,556 | Mar 12, 2025 |
| CHENG ANDREW Chief Executive Officer | Sale at price 41.75 - 42.31 per share. | Direct | 1,253,069 | Mar 10, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 44.40 - 44.90 per share. | Direct | 556,590 | Mar 5, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 263,750 | Mar 5, 2025 |
| YOUNG JONATHAN Chief Operating Officer | Sale at price 44.17 - 45.07 per share. | Direct | 2,243,213 | Mar 4, 2025 |
| LAMY PATRICK Officer | Sale at price 48.09 per share. | Direct | 48,090 | Mar 3, 2025 |
| LAMY PATRICK Officer | Conversion of Exercise of derivative security at price 19.87 per share. | Direct | 19,870 | Mar 3, 2025 |
| YALE CATRIONA Officer | Sale at price 49.79 - 50.63 per share. | Direct | 498,660 | Feb 18, 2025 |
| YALE CATRIONA Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 211,000 | Feb 18, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 56.33 - 56.92 per share. | Direct | 1,059,630 | Feb 5, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 21.10 per share. | Direct | 395,625 | Feb 5, 2025 |
| YOUNG JONATHAN Chief Operating Officer | Sale at price 53.56 - 54.06 per share. | Direct | 538,061 | Feb 3, 2025 |
| GRAHAM G. WALMSLEY Director | Purchase at price 48.00 per share. | Indirect | 9,600,000 | Jan 30, 2025 |
| ROLPH TIMOTHY PETER Officer | Sale at price 54.76 - 56.97 per share. | Direct | 1,742,958 | Jan 27, 2025 |
| ROLPH TIMOTHY PETER Officer | Conversion of Exercise of derivative security at price 19.87 - 21.10 per share. | Direct | 640,942 | Jan 27, 2025 |
| CHENG ANDREW Chief Executive Officer | Sale at price 54.56 - 56.89 per share. | Direct | 1,646,978 | Jan 27, 2025 |
| YALE CATRIONA Officer | Sale at price 55.15 - 57.01 per share. | Direct | 2,734,212 | Jan 27, 2025 |
Related Tickers
ETNB 89bio, Inc.
10.57
+3.12%
MDGL Madrigal Pharmaceuticals, Inc.
280.24
+0.72%
SRRK Scholar Rock Holding Corporation
34.07
-0.47%
PTGX Protagonist Therapeutics, Inc.
55.68
+2.39%
STOK Stoke Therapeutics, Inc.
11.13
-0.09%
CYTK Cytokinetics, Incorporated
33.13
+2.57%
PCVX Vaxcyte, Inc.
37.20
+0.57%
TRVI Trevi Therapeutics, Inc.
6.41
-9.21%
MTSR Metsera, Inc.
30.39
+10.55%
VRNA Verona Pharma plc
84.64
+0.36%